If you have pulmonary arterial hypertension, or PAH, it means that you have high blood pressure in your pulmonary arteries-- the blood vessels that carry blood from your heart to your lungs.
Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...
In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...
?] Pulmonary arterial hypertension happens when the arteries that carry blood from your heart to your lungs get narrow or blocked. This makes the blood pressure inside these arteries go up, and ...
Gossamer Bio Inc. has released new data showing its inhaled kinase inhibitor, seralutinib, has long-lasting effects on ...
Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...
Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.
The phase 3 HYPERION trial of Winrevair in adults with newly diagnosed pulmonary arterial hypertension functional class two ...
Natco Pharma gains FDA approval for generic Bosentan tablets, partnering with Lupin Pharmaceuticals for U.S. marketing.
The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback